{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T10:36:23Z","timestamp":1768559783935,"version":"3.49.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>IMPORTANCE:<\/jats:title>\n            <jats:p>Previous findings suggest that bacterial coinfections are less common in ICU patients with COVID-19 than with influenza, but evidence is limited.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>This study aimed to compare the rate of early bacterial coinfections in ICU patients with COVID-19 or influenza.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN, SETTING AND PARTICIPANTS:<\/jats:title>\n            <jats:p>Retrospective propensity score matched cohort study. We included patients admitted to ICUs of a single academic center with COVID-19 or influenza (January 2015 to April 2022).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MAIN OUTCOMES AND MEASURES:<\/jats:title>\n            <jats:p>The primary outcome was early bacterial coinfection (i.e., positive blood or respiratory culture within 2 d of ICU admission) in the propensity score matched cohort. Key secondary outcomes included frequency of early microbiological testing, antibiotic use, and 30-day all-cause mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Out of 289 patients with COVID-19 and 39 patients with influenza, 117 (<jats:italic toggle=\"yes\">n<\/jats:italic> = 78 vs 39) were included in the matched analysis. In the matched cohort, the rate of early bacterial coinfections was similar between COVID-19 and influenza (18\/78 [23%] vs 8\/39 [21%]; odds ratio, 1.16; 95% CI, 0.42\u20133.45; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.82). The frequency of early microbiological testing and antibiotic use was similar between the two groups. Within the overall COVID-19 group, early bacterial coinfections were associated with a statistically significant increase in 30-day all-cause mortality (21\/68 [30.9%] vs 40\/221 [18.1%]; hazard ratio, 1.84; 95% CI, 1.01\u20133.32).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS AND RELEVANCE:<\/jats:title>\n            <jats:p>Our data suggest similar rates of early bacterial coinfections in ICU patients with COVID-19 and influenza. In addition, early bacterial coinfections were significantly associated with an increased 30-day mortality in patients with COVID-19.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cce.0000000000000895","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T18:00:06Z","timestamp":1681149606000},"page":"e0895","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Early Bacterial Coinfections in Patients Admitted to the ICU With COVID-19 or Influenza: A Retrospective Cohort Study"],"prefix":"10.1097","volume":"5","author":[{"given":"Felix","family":"Bergmann","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria."},{"name":"Department of Plastic, Reconstructive and Aesthetic Surgery, Medical University of Vienna, Vienna, Austria."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia","family":"Gabler","sequence":"additional","affiliation":[{"name":"IT Systems and Communications, Medical University of Vienna, Vienna, Austria."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Nussbaumer-Pr\u00f6ll","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"W\u00f6lfl-Duchek","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria."},{"name":"Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna Austria."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelie","family":"Blaschke","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria."},{"name":"Department of Infectiology and Tropical Medicine, University Clinic of Internal Medicine I, Medical University Vienna, Vienna, Austria."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Radtke","sequence":"additional","affiliation":[{"name":"Department of Plastic, Reconstructive and Aesthetic Surgery, Medical University of Vienna, Vienna, Austria."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Zeitlinger","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anselm","family":"Jorda","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,4,10]]},"reference":[{"key":"R1-20240807","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MCP.0000000000000666","article-title":"Viral respiratory infections: A cause of community-acquired pneumonia or a predisposing factor?","volume":"26","author":"Arnold","year":"2020","journal-title":"Curr Opin Pulm Med"},{"key":"R2-20240807","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3390\/pathogens11040445","article-title":"The prevalence and impact of coinfection and superinfection on the severity and outcome of COVID-19 infection: An updated literature review.","volume":"11","author":"Omoush","year":"2022","journal-title":"Pathogens"},{"key":"R3-20240807","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/irv.12089","article-title":"Bacterial and viral infections associated with influenza.","volume":"7","author":"Joseph","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"R4-20240807","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00134-016-4578-y","article-title":"Increased incidence of co-infection in critically ill patients with influenza.","volume":"43","author":"Martin-Loeches","year":"2017","journal-title":"Intensive Care Med"},{"key":"R5-20240807","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1097\/CCM.0b013e3182416f23","article-title":"Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States.","volume":"40","author":"Rice","year":"2012","journal-title":"Crit Care Med"},{"key":"R6-20240807","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1378\/chest.10-1396","article-title":"Community-acquired respiratory coinfection in critically ill patients with pandemic 2009 influenza A(H1N1) virus.","volume":"139","author":"Mart\u00edn-Loeches","year":"2011","journal-title":"Chest"},{"key":"R7-20240807","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/cid\/ciy874","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza.","volume":"68","author":"Uyeki","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R8-20240807","doi-asserted-by":"crossref","first-page":"e354","DOI":"10.1016\/S2666-5247(21)00090-2","article-title":"Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: A multicentre, prospective cohort study.","volume":"2","author":"Russell","year":"2021","journal-title":"Lancet Microbe"},{"key":"R9-20240807","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.cmi.2020.07.016","article-title":"Bacterial co-infection and secondary infection in patients with COVID-19: A living rapid review and meta-analysis.","volume":"26","author":"Langford","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"R10-20240807","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1164\/rccm.202101-0030OC","article-title":"Early bacterial identification among intubated patients with COVID-19 or influenza pneumonia: A European multicenter comparative clinical trial.","volume":"204","author":"Rouz\u00e9","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"R11-20240807","first-page":"2459","article-title":"Bacterial and fungal coinfection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing.","volume":"71","author":"Rawson","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R12-20240807","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13054-022-04026-9","article-title":"Comparative incidence of early and late bloodstream and respiratory tract co-infection in patients admitted to ICU with COVID-19 pneumonia versus influenza A or B pneumonia versus no viral pneumonia: Wales multicentre ICU cohort study.","volume":"26","author":"Pandey","year":"2022","journal-title":"Crit Care"},{"key":"R13-20240807","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1164\/rccm.202106-1467ED","article-title":"Bacterial coinfection in COVID-19 and influenza pneumonia.","volume":"204","author":"Musher","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"R14-20240807","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies.","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"key":"R15-20240807","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1710-1492-9-30","article-title":"A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy.","volume":"9","author":"Liu","year":"2013","journal-title":"Allergy Asthma Clin Immunol"},{"key":"R16-20240807","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v042.i08","article-title":"MatchIt: Nonparametric Preprocessing for Parametric Causal Inference.","volume":"42","author":"Ho","year":"2011","journal-title":"J Stat Softw"},{"key":"R17-20240807","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies.","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"R18-20240807","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s00134-020-06022-5","article-title":"Surviving sepsis campaign: Guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19).","volume":"46","author":"Alhazzani","year":"2020","journal-title":"Intensive Care Med"},{"key":"R20-20240807","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13613-020-00736-x","article-title":"Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU.","volume":"10","author":"Contou","year":"2020","journal-title":"Ann Intensive Care"},{"key":"R21-20240807","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-020-0395-y","article-title":"Antimicrobial use, drug-resistant infections and COVID-19.","volume":"18","author":"Rawson","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"R22-20240807","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/jac\/dkaa194","article-title":"COVID-19 and the potential long-term impact on antimicrobial resistance.","volume":"75","author":"Rawson","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"R23-20240807","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1001\/jama.2020.2717","article-title":"Prevalence and outcomes of infection among patients in intensive care units in 2017.","volume":"323","author":"Vincent","year":"2020","journal-title":"JAMA"},{"key":"R24-20240807","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12941-021-00468-1","article-title":"Antimicrobial susceptibility patterns of respiratory Gram-negative bacterial isolates from COVID-19 patients in Switzerland.","volume":"20","author":"Gysin","year":"2021","journal-title":"Ann Clin Microbiol Antimicrob"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000895","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T11:01:20Z","timestamp":1723028480000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":23,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000000895","relation":{},"ISSN":["2639-8028"],"issn-type":[{"value":"2639-8028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4]]}}}